These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2640620)

  • 1. About a case of human hepatic distomatosis.
    Ioli A; Lo Giudice L; Fossari MT; Vasi A
    Bull Inst Marit Trop Med Gdynia; 1989; 40(1-2):95-6. PubMed ID: 2640620
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of antibodies and circulating excretory-secretory antigens for assessing cure in patients with fascioliasis.
    Espino AM; Millán JC; Finlay CM
    Trans R Soc Trop Med Hyg; 1992; 86(6):649. PubMed ID: 1287933
    [No Abstract]   [Full Text] [Related]  

  • 3. Human fascioliasis.
    Saba R; Korkmaz M; Inan D; Mamikoğlu L; Turhan O; Günseren F; Cevikol C; Kabaalioğlu A
    Clin Microbiol Infect; 2004 May; 10(5):385-7. PubMed ID: 15113313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of immunologic techniques to predict success of therapy in human fascioliasis: a case report.
    Hillyer GV; Bermúdez RH; Ramírez de Arellano G
    Bol Asoc Med P R; 1984 Mar; 76(3):116-9. PubMed ID: 6372829
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serological diagnosis of Fasciola hepatica distomatosis. Study of 7 cases].
    García-Rodríguez JA; Martín Sánchez AM; García Luis EJ
    Med Clin (Barc); 1985 Jun; 85(5):179-82. PubMed ID: 3927088
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy and tolerance of praziquantel (Biltricide) in the treatment of distomatosis caused by Fasciola hepatica].
    Moreau JA; Fernandez J; Recco P; Seguela JP; Frexinos J
    Gastroenterol Clin Biol; 1995 May; 19(5):514-9. PubMed ID: 7590004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pseudotumor form of hepatic distomatosis: successful treatment with praziquantel].
    Queneau PE; Koch S; Bresson-Hadni S; Bartholomot B; Arbez-Gindre F; Heyd B; Miguet JP
    Gastroenterol Clin Biol; 1997; 21(6-7):511-3. PubMed ID: 9295980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distomatosis: diagnosis and treatment].
    Delasalle P; Beytout J; Cambon M; Bommelaer G
    Rev Prat; 1990 Jan; 40(3):230-6. PubMed ID: 2305189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fascioliasis hepatica: diagnosis by endoscopic retrograde cholangiopancreatography].
    Apt W; Tiselj R
    Rev Med Chil; 1987 Jun; 115(6):564-8. PubMed ID: 3453522
    [No Abstract]   [Full Text] [Related]  

  • 10. [Purification of antigenic fraction 27-28 kDa from the metabolic antigen from metabolic secreted-excreted from Fasciola hepatica].
    Antitupa I; Quispe W; Mayo J; Valverde F; Sanchez E
    Rev Peru Med Exp Salud Publica; 2014 Apr; 31(2):288-91. PubMed ID: 25123868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fasciola hepatica].
    Aguirre Errasti C
    Med Clin (Barc); 1984 May; 82(17):756-8. PubMed ID: 6738192
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of immunosorbent-purified antigens of Fasciola hepatica in enzyme immunoassays.
    Trudgett A; Anderson A; Hanna RE
    Res Vet Sci; 1988 Mar; 44(2):262-3. PubMed ID: 3291031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fasciola hepatica antigens. Use in the diagnosis of human fascioliasis].
    Espino Hernández AM; Seuret N; Morlote C; Duménigo Ripoll B
    Rev Cubana Med Trop; 1991; 43(3):151-5. PubMed ID: 9768179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human fascioliasis in Cajamarca/Peru. I. Diagnostic methods and treatment with praziquantel.
    Knobloch J; Delgado E; Alvarez A; Reymann U; Bialek R
    Trop Med Parasitol; 1985 Jun; 36(2):88-90. PubMed ID: 4023557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of crude and purified Fasciola antigens in immunodiagnosis of human fascioliasis.
    Khalil HM; Abdel TM; Maklad MK; Abdallah HM; Fahmy IA; el Zayyat EA
    J Egypt Soc Parasitol; 1990 Jun; 20(1):87-94. PubMed ID: 1692074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified method for preparation of antigens of Japanese Fasciola sp. for double immunodiffusion.
    Kawano J; Yamamoto H; Shimizu A; Kimura S
    Nihon Juigaku Zasshi; 1985 Aug; 47(4):611-6. PubMed ID: 3930822
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of purified antigens in haemagglutination test (IHA) for determination of cross reactivities in diagnosis of fascioliasis and schistosomiasis.
    Azab M el-S ; el Zayat EA
    J Egypt Soc Parasitol; 1996 Dec; 26(3):677-85. PubMed ID: 8918041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic distomatosis due to "fasciola hepatica"; early diagnosis and treatment. Apropos of 30 cases].
    Delumeau G; Magois JY; Depagne A
    Arch Fr Mal App Dig; 1966 Sep; 55(9):826. PubMed ID: 5981231
    [No Abstract]   [Full Text] [Related]  

  • 19. Indirect evidence of ectopic pancreatic fascioliasis in a human.
    Lee OJ; Kim TH
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1631-3. PubMed ID: 16928233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of human fascioliasis--long-term follow up with imaging procedures and immunoserological test].
    Hamamoto T; Fujise M; Hoshino U; Kadohara M; Horie Y; Suo T; Kawasaki H
    Nihon Shokakibyo Gakkai Zasshi; 1992 Mar; 89(3):657-61. PubMed ID: 1578812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.